Advertisement
Advertisement
Trending on Urology Times
1
FDA grants tentative approval to generic olaparib tablets across previously approved indications
2
Phase 3 trial launches of CAIX-targeted radiopharmaceutical for ccRCC
3
KEYNOTE-B15 data on enfortumab vedotin plus pembrolizumab in MIBC published in NEJM
4
Experts discuss the challenge of detecting CIS in bladder cancer
5